Daten werden ergänzt – lade die Seite später neu, um den aktuellen Stand zu sehen
1069-48-3C=CCC(N)C(=O)OWNNNWFKQCKFSDK-UHFFFAOYSA-NAllylglycine is a glycine derivative that is glycine substituted by a prop-1-en-3-yl group at position 2. It has a role as an EC 4.1.1.15 (glutamate decarboxylase) inhibitor. It is a glycine derivative, an alpha-amino acid and an olefinic compound.
1069-48-3、7685-44-1DTXSID701313217CHEMBL4096969Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.
Warning
H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]
P261, P264, P264+P265, P271, P272, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P333+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 44 reports by companies from 7 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Substances that act in the brain stem or spinal cord to produce tonic or clonic convulsions, often by removing normal inhibitory tone. They were formerly used to stimulate respiration or as antidotes to barbiturate overdose. They are now most commonly used as experimental tools.
Drugs that bind to but do not activate GABA RECEPTORS, thereby blocking the actions of endogenous GAMMA-AMINOBUTYRIC ACID and GABA RECEPTOR AGONISTS.
CHEBI:231976